Model-informed precision dosing: State of the art and future perspectives
-
Published:2024-08
Issue:
Volume:
Page:115421
-
ISSN:0169-409X
-
Container-title:Advanced Drug Delivery Reviews
-
language:en
-
Short-container-title:Advanced Drug Delivery Reviews
Author:
Minichmayr I.K., Dreesen E., Centanni M., Wang Z., Hoffert Y., Friberg L.E., Wicha S.G.ORCID
Reference385 articles.
1. Immunoassays in therapeutic drug monitoring;Blecka;Clin. Lab. Med.,1987 2. Computer-aided long-term anticoagulation therapy;Sheiner;Comput. Biomed. Res.,1969 3. Reduction of digitalis toxicity by computer-assisted glycoside dosage regimens;Jelliffe;Ann. Intern. Med.,1972 4. D. Samineni, K. Venkatakrishnan, A.A. Othman, Y.K. Pithavala, S. Poondru, C. Patel, P. Vaddady, W. Ankrom, S. Ramanujan, N. Budha, M. Wu, N. Haddish-Berhane, H. Fritsch, A. Hussain, J. Kanodia, M. Li, M. Li, M. Melhem, A. Parikh, V.V. Upreti, N. Gupta, Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper, Clin Pharmacol Ther (2024). Doi: 10.1002/cpt.3298. (Online ahead of print). 5. Rapid monitoring of vancomycin concentration in serum using europium (III) chelate nanoparticle-based lateral flow immunoassay;Bian;Front. Chem.,2021
|
|